96 results
Page 3 of 5
DEFA14A
oxntm19wr
22 Apr 21
Additional proxy soliciting materials
4:49pm
8-K
EX-99.1
pipfcr7
31 Mar 21
Yumanity Therapeutics Reports Full Year 2020 Financial Results and Recent Corporate Developments
8:55am
8-K/A
EX-99.1
q72x7t2
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.2
efduwbs
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.4
6cf8mb
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.7
s07uw1r80k 4w
3 Feb 21
Other Events
4:59pm
8-K
EX-10.2
k0nor2t
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-10.1
ge7xwq3hl
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
424B3
d60 p2v1qgrraobxq
12 Nov 20
Prospectus supplement
6:08am
S-4/A
ge1ji82oxbfkadedrn
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4
EX-10.19
6gj i81fh
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
EX-10.16
b3xjg1ae00 l7
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
zz4kb8gour2hw7ez3ou2
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
EX-2.1
lsoszvia qwss
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-2.2
lyy33zxn 4971bpo27h9
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.1
rsmk0lpb9rup
24 Aug 20
Business combination disclosure
5:28pm